Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo. - Test2 - elhamkhani - TriplyDB

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

http://www.wikidata.org/entity/Q35157103

about

Carbohydrate-derived amphiphilic macromolecules: a biophysical structural characterization and analysis of binding behaviors to model membranes.Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesion Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.PEG-b-PCL polymeric nano-micelle inhibits vascular angiogenesis by activating p53-dependent apoptosis in zebrafish.Synthetic multivalency for biological applications.Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.Nanomedicines for dysfunctional macrophage-associated diseases.Natural Biflavonoids Modulate Macrophage-Oxidized LDL Interaction In Vitro and Promote Atheroprotection In Vivo.Continuous Production of Discrete Plasmid DNA-Polycation Nanoparticles Using Flash Nanocomplexation.Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.Computational Analysis on Down-Regulated Images of Macrophage Scavenger Receptor.Multiscale technologies for treatment of ischemic cardiomyopathy.Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages.Recent Advances in Managing Atherosclerosis via Nanomedicine.Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis.Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.A review on core-shell structured unimolecular nanoparticles for biomedical applications A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity

P2860

Q35824486-F983C0CC-E789-43FA-9D08-5ED98C19CE93 Q36496336-A08DAC7D-4750-4CCA-9CDB-30C7CACD4C1D Q36586068-699B6E6B-1FDB-47D0-BCAD-1F55B8111DAA Q36598388-B2CDB066-6481-46B0-9405-2E050B835D22 Q36602809-F6EA4993-0123-4EC4-83DB-E58040BF6751 Q37488903-C7514F6C-43CD-4DEE-BFE9-1D8F7F1911C0 Q38598783-E67B90D1-410B-4B24-A510-57570750CFC5 Q38682030-F750D2C4-B0CD-4718-9740-64F6F984FCF1 Q38858690-BCFBAE40-31D2-472C-B745-86D8BB4D543A Q39069052-5AD354C9-6E72-43C0-B738-A26EA6F6674B Q39504039-AD56CB2E-3F39-4776-916E-B3BE451CC82E Q45346878-422B096C-C719-4918-B4D1-F6C6AFCFB18A Q45814729-6E7D115A-FA18-43C7-B18F-85DC94B6097C Q46382974-2667465F-2F4F-4E31-82FB-8363995D8A3C Q46454164-4C7C564D-8814-4114-952A-73BC970D1F9C Q46513033-E50E7C74-05F4-4DE0-AE71-F6572C44BCAA Q47251361-7D76A788-3659-4BD0-9B8E-614C2F386C66 Q48114789-23350676-B421-4F3D-A911-ADEE91C3FBEB Q50222895-9DA62C31-6F80-4AD1-97B4-4DD950969DDC Q57179221-037891F9-1B62-4D70-9C4A-FFECB9949E66 Q57823849-3CD11E11-2C55-4D5D-9CC9-62DEAB643063

P2860

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

http://www.wikidata.org/entity/Q35157103

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@ast

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@en

type

label

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@ast

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@en

prefLabel

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@ast

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@en

P1433

Q35157103-89A69378-33DE-4AC0-899D-1EDCEB0A9654

P1476

Q35157103-EB0CD0C3-B16F-457B-8235-4AD0C80C4FCB

P2093

Q35157103-07AE1877-B878-4B56-BE64-68D76360D64A

Q35157103-145B25E3-9706-4DA0-874B-A7E603CBDDC6

Q35157103-2B2C8818-B639-4F8E-BA42-8FAB046BA42C

Q35157103-2DE2B197-C711-4E09-8EC1-07AAAED4743C

Q35157103-7C58EDE6-10F5-492C-AF7D-CBEEC1EAB2A4

Q35157103-940679F6-99DE-4948-97E2-FC21FD9B54E6

Q35157103-9E5EB211-7783-47A9-BA21-1D4DE40C8805

Q35157103-9F769FA3-41B7-47D6-AD5B-8F1E24831DBB

P2860

Q35157103-022573E9-0B5D-42DB-83D3-8A27E2FAA65A

Q35157103-0DDEC8B3-B186-490A-BDC8-62310559C038

Q35157103-1C29427E-14DD-4F5E-A33C-2A0E06A7C3E5

Q35157103-24D0497C-BFB7-40FF-BA6B-F4EB567CBC9A

Q35157103-46F05953-A413-4A68-A10B-809BD35AF9B7

Q35157103-48EBBE13-172E-455C-9D22-F29D218748DF

Q35157103-4AB3EB43-4E55-4174-ADA9-5198087E62EF

Q35157103-4FD9A7C9-EF86-4A27-9C47-53391619D677

Q35157103-55C18433-9B4E-47AD-94B6-6118AFCD1EDF

Q35157103-57625859-0FA5-4840-B460-019EA13F7375

P304

Q35157103-069C2353-7C36-4811-8399-28026AE0C6DB

P31

Q35157103-35918272-33DA-4C8A-A379-A24AC246492D

P356

Q35157103-D678DFD8-3E57-4733-B8CA-25205EBF63C5

P407

Q35157103-5C9281A6-8535-49F4-AE6B-0705D32C90E3

P433

Q35157103-411BC836-A3D9-43F3-8B03-951B1BB9F770

P478

Q35157103-12B7B108-731A-49CF-8FBD-A0735DB70B2A

P50

Q35157103-45E0AFB4-050E-4815-88FE-427768E84D87

P577

Q35157103-75B5C395-81C9-4B14-95B1-E7364908738C

P5875

Q35157103-2DCB83C1-C8F8-497D-81CB-1AA2C187AB76

P698

Q35157103-548F3189-63D8-4414-995E-C4833228C9BA

P921

Q35157103-6F19B5FF-7E41-41C3-9142-3BC50FFDE604

Q35157103-7047A469-35DD-4040-92B4-28370CEA4B8C

P932

Q35157103-4D4C3DF3-8863-4663-9BBB-700BC3225247

P356

PNAS.1424594112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

@en

P2093

Adam W York

http://www.w3.org/2001/XMLSchema#string

Daniel R Lewis

http://www.w3.org/2001/XMLSchema#string

Kyle R Zablocki

http://www.w3.org/2001/XMLSchema#string

Latrisha K Petersen

http://www.w3.org/2001/XMLSchema#string

Laurie B Joseph

http://www.w3.org/2001/XMLSchema#string

Prabhas V Moghe

http://www.w3.org/2001/XMLSchema#string

Robert K Prud'homme

http://www.w3.org/2001/XMLSchema#string

Vladyslav Kholodovych

http://www.w3.org/2001/XMLSchema#string

P2860

Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Renal clearance of quantum dots.

Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture

Coronary-artery stents

Systematic review on the risk and benefit of different cholesterol-lowering interventions

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Inflammation and atherosclerosis

Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

P304

2693-2698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1424594112

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272513906

http://www.w3.org/2001/XMLSchema#string

P698

25691739

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4352838

http://www.w3.org/2001/XMLSchema#string